Peterson Amy C. 4
4 · CytomX Therapeutics, Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Peterson Amy C.
EVP, Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-26+250,000→ 250,000 totalExercise: $7.85Exp: 2031-02-25→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest on each monthly anniversary measured from February 26, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.